203 related articles for article (PubMed ID: 32170782)
1. Systematic review with meta-analysis: biologics and risk of infection or cancer in elderly patients with inflammatory bowel disease.
Piovani D; Danese S; Peyrin-Biroulet L; Nikolopoulos GK; Bonovas S
Aliment Pharmacol Ther; 2020 May; 51(9):820-830. PubMed ID: 32170782
[TBL] [Abstract][Full Text] [Related]
2. Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis.
Borren NZ; Ananthakrishnan AN
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1736-1743.e4. PubMed ID: 30616024
[TBL] [Abstract][Full Text] [Related]
3. Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis.
Bonovas S; Fiorino G; Allocca M; Lytras T; Nikolopoulos GK; Peyrin-Biroulet L; Danese S
Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1385-1397.e10. PubMed ID: 27189910
[TBL] [Abstract][Full Text] [Related]
4. Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.
Singh S; Facciorusso A; Dulai PS; Jairath V; Sandborn WJ
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):69-81.e3. PubMed ID: 30876964
[TBL] [Abstract][Full Text] [Related]
5. Biologics During Pregnancy in Women With Inflammatory Bowel Disease and Risk of Infantile Infections: A Systematic Review and Meta-Analysis.
Gubatan J; Nielsen OH; Levitte S; Juhl CB; Maxwell C; Streett SE; Habtezion A
Am J Gastroenterol; 2021 Feb; 116(2):243-253. PubMed ID: 33110017
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory Bowel Disease (IBD) pharmacotherapy and the risk of serious infection: a systematic review and network meta-analysis.
Wheat CL; Ko CW; Clark-Snustad K; Grembowski D; Thornton TA; Devine B
BMC Gastroenterol; 2017 Apr; 17(1):52. PubMed ID: 28407755
[TBL] [Abstract][Full Text] [Related]
7. Risk of Infection and Types of Infection Among Elderly Patients With Inflammatory Bowel Disease: A Retrospective Database Analysis.
Khan N; Vallarino C; Lissoos T; Darr U; Luo M
Inflamm Bowel Dis; 2020 Feb; 26(3):462-468. PubMed ID: 30980714
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
Goessens L; Colombel JF; Outtier A; Ferrante M; Sabino J; Judge C; Saeidi R; Rabbitt L; Armuzzi A; Domenech E; Michalopoulos G; Cremer A; García-Alonso FJ; Molnar T; Karmiris K; Gecse K; Van Oostrom J; Löwenberg M; Farkas K; Atreya R; Ribaldone DG; Selinger C; Hoentjen F; Bihin B; Sebastian S; ; Rahier JF
United European Gastroenterol J; 2021 Dec; 9(10):1136-1147. PubMed ID: 34694746
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.
Mikocka-Walus A; Prady SL; Pollok J; Esterman AJ; Gordon AL; Knowles S; Andrews JM
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012680. PubMed ID: 30977111
[TBL] [Abstract][Full Text] [Related]
10. Nested case-control study on risk factors for opportunistic infections in patients with inflammatory bowel disease.
Gong SS; Fan YH; Han QQ; Lv B; Xu Y
World J Gastroenterol; 2019 May; 25(18):2240-2250. PubMed ID: 31143074
[TBL] [Abstract][Full Text] [Related]
11. Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development.
Matro R; Martin CF; Wolf D; Shah SA; Mahadevan U
Gastroenterology; 2018 Sep; 155(3):696-704. PubMed ID: 29857090
[TBL] [Abstract][Full Text] [Related]
12. Safety of biologics in inflammatory bowel disease patients with COVID-19.
Weissman S; Aziz M; Smith WL; Elias S; Swaminath A; Feuerstein JD
Int J Colorectal Dis; 2021 Sep; 36(9):2051-2055. PubMed ID: 34131784
[TBL] [Abstract][Full Text] [Related]
13. Complications of biologics in inflammatory bowel disease.
Sousa P; Allez M
Curr Opin Gastroenterol; 2015 Jul; 31(4):296-302. PubMed ID: 26039721
[TBL] [Abstract][Full Text] [Related]
14. The use of biologic therapy in pregnancy: a gastroenterologist's perspective.
Hassid B; Mahadevan U
Curr Opin Rheumatol; 2014 May; 26(3):347-53. PubMed ID: 24625373
[TBL] [Abstract][Full Text] [Related]
15. Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease.
Hyams JS; Dubinsky MC; Baldassano RN; Colletti RB; Cucchiara S; Escher J; Faubion W; Fell J; Gold BD; Griffiths A; Koletzko S; Kugathasan S; Markowitz J; Ruemmele FM; Veereman G; Winter H; Masel N; Shin CR; Tang KL; Thayu M
Gastroenterology; 2017 Jun; 152(8):1901-1914.e3. PubMed ID: 28193515
[TBL] [Abstract][Full Text] [Related]
16. Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection.
Solanky D; Pardi DS; Loftus EV; Khanna S
Inflamm Bowel Dis; 2019 Feb; 25(3):610-619. PubMed ID: 30260451
[TBL] [Abstract][Full Text] [Related]
17. Patient Understanding of the Risks and Benefits of Biologic Therapies in Inflammatory Bowel Disease: Insights from a Large-scale Analysis of Social Media Platforms.
Martinez B; Dailey F; Almario CV; Keller MS; Desai M; Dupuy T; Mosadeghi S; Whitman C; Lasch K; Ursos L; Spiegel BMR
Inflamm Bowel Dis; 2017 Jul; 23(7):1057-1064. PubMed ID: 28410343
[TBL] [Abstract][Full Text] [Related]
18. The impact of surgical therapies for inflammatory bowel disease on female fertility.
Lee S; Crowe M; Seow CH; Kotze PG; Kaplan GG; Metcalfe A; Ricciuto A; Benchimol EI; Kuenzig ME
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012711. PubMed ID: 31334846
[TBL] [Abstract][Full Text] [Related]
19. [Risk of infections associated with the use of biological medications; a review].
Gambra MP; Montesinos JJ; Valenzuela MT; Cárcamo ME; Cavada Ch G
Rev Med Chil; 2020 Aug; 148(8):1155-1170. PubMed ID: 33399782
[TBL] [Abstract][Full Text] [Related]
20. Market share and costs of biologic therapies for inflammatory bowel disease in the USA.
Yu H; MacIsaac D; Wong JJ; Sellers ZM; Wren AA; Bensen R; Kin C; Park KT
Aliment Pharmacol Ther; 2018 Feb; 47(3):364-370. PubMed ID: 29164650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
